Introduction
The dense and diverse gut microbiome that transforms their hosts to superorganisms plays a crucial role in host metabolic, physiological and immunological processes. The symbiotic association of microbiota that co-evolved with their host (Van den Abbeele et al., 2011) produces a widearray of microbial metabolites [e.g., short-chain fatty acids (SCFA), secondary bile acids, and vitamins] that are beneficial to the host (Nicholson et al., 2012 ). These microbial metabolites are then taken up and recognized by host cells/receptors, which subsequently, initiate various physiological and immunological responses and pathways. For example, the recognition of SCFA via G-coupled protein receptors (transmembrane receptors) expressed on immune cells in the gut mucosa induces anti-inflammatory responses (Smith et al., 2013) , which are crucial for the maintenance of mucosal immune homeostasis. The induction of anti-inflammatory responses in the mucosal immune system is necessary for the maintenance of the intestinal barrier integrity. Thus, this explains the metabolic role of symbiotic gut microbiota, which produces SCFA, in immunological processes to maintain proper intestinal barrier functions (physiology). Such crosstalk between a host and its symbiotic microbiota that impacts the host physiology has led to phenotypic variations among individuals. Therefore, studies on the gut microbiome have been widely used to identify potential microbial markers that can identify or predict microbiota-driven host phenotypes, such as susceptibility to enteric infections and risk of developing metabolic disorders. Human and mouse studies suggest that individual variations in gut microbiota composition and its abundance are strongly linked to metabolic disorders (obesity), inflammatory bowel diseases (Crohn's disease and ulcerative colitis), allergies, and autoimmune diseases (type 2 diabetes) (Sekirov et al., 2010) . Most of these findings are based on a rapidly increasing number of studies exploring host-microbial interactions with the introduction of "omics" based approaches, which are capable of profiling large numbers of samples at once to capture unculturable microbiota residing in the gut using high-throughput techniques.
The gut microbiome, which is usually defined as the total genome of microbiota that resides in the gut, can be studied at compositional and functional levels using amplicon-based sequencing methods and omics approaches, respectively (Table 1) . Amplicon-based sequencing techniques describe "who they are" while omics approaches (metagenomics, metatranscriptomics, metaproteomics, and meta-metabolomics) describe "what they do." Although it is still debated which of these is more important in terms of defining host physiology, most of the researchers concur that compositional-based studies may provide easily detectable biomarkers and that functional-based studies can better elucidate the mechanisms behind host-microbial interactions. For example, obesity was first linked to the changes in gut microbial composition, and a high ratio between the abundances of Firmicutes:Bacteroidetes was identified as a microbial marker of the disease/metabolic dysfunction phenotype (Ley et al., 2006) . Subsequently, the use of metagenomics (study of overall genetic material from a microbiome) suggested that the more efficient energy harvesting capability of Firmicutes compared with Bacteroidetes increased the availability of nutrients for the host, which led to obesity (Turnbaugh et al., 2009 ). Further differences in cecal meta-metabolomics profiles were reported recently in mice during high-fat diet-induced obesity (Walker et al., 2014) , suggesting that such host phenotypes could be further clarified using microbial metabolism and their metabolites.
Use of Omics to Define Animal Physiology and Health
Omics approaches allow exploring microbiomes at their various functional levels, such as gene abundance, gene expression, protein expression, metabolite profile and the level/intensity of metabolites (Table 1) . These techniques are widely used in human and mouse studies that try to define human disease/metabolic dysfunction phenotypes based on microbial activity in the gut. However, efforts in understanding the function of the rumen microbiome in efficient cattle using metagnomics-based functional analysis Gut microbiome and omics: a new definition to ruminant production and health Nilusha Malmuthuge,* and Le Luo Guan* *Department of Agricultural, Food, and Nutritional Science, University of Alberta, Edmonton, Alberta, Canada T6G 2P5
Implications
• Mammalians are considered as "superorganisms" due to the presence of dense and dynamic microbiota in the digestive tract that perform a wide range of metabolically, immunologically, and physiologically crucial tasks.
• The composition and functions of gut microbiota have been studied using "omics" based approaches without isolation and cultivation of microbes.
• Omics have been used in defining host phenotypes, such as susceptibility to diseases in humans.
• In-depth analyses of the ruminant gut microbiome (rumen and lower gut) using "omics" will help identifying microbial biomarkers that may define production and health phenotypes/susceptibility to diseases in the future.
have just started (Ghoshal et al., 2013; Wallace et al., 2015) . The use of metagenomics approach has reported that low-abundant taxa may contribute largely to the microbial functions in the gut (Arumugam et al., 2011) , suggesting the importance of co-evolved gut microbiota regardless of its abundance. Compositional-based studies have always concentrated on the changes in highly abundant taxa with the assumption that they play important roles in determining host phenotypes. However, the discovery of low abundant, yet highly functional taxa, suggests that these microbiotas may also play significant roles in host physiology. A recent study suggests that the presence of Christensenella in the gut, a low abundant (less than 0.001%) and highly heritable (transmissible from parent to offspring) bacterial genus, decreases body weight gain in obese mice (Goodrich et al., 2014) , confirming the claim that low abundant microbiota has an impact on host physiology. Nonetheless, such a claim still requires validation in terms of functionality to verify the mechanisms behind the reduced body weight gain in the presence of Christensenella. Therefore, the combined study of microbial composition and functions may aid in identifying important biomarkers that can be used to define host phenotypes. Besides revealing the importance of low abundant microbiota in the host physiology, Arumugam et al. (2011) used metagenomics to categorize humans into three broad cohorts, known as enterotypes, based on their gut microbiota. Thus, this suggests that the microbiota can also be used to categorize host populations broadly. These broad categories may later be used to subdivide the host phenotypes based on other external factors, such as diet, incidences of diseases, and medical interventions (antibiotic/xenobiotic treatments). Such a categorization can even be more applicable for livestock, since their management can be affected by various factors such as diet, breed, environment, and age.
Use of Omics in Ruminant Production
The use of omics in livestock, especially in ruminants, is still at the preliminary level. However, there are increasing numbers of studies that have explored the rumen microbiome using omics approaches and linked the composition of this microbiome and its functions to host production and health phenotypes. Most of these omics-based studies explored the taxonomic changes in rumen content and fluid-associated microbiota under different diets and environmental conditions as well as the functions of their fiber digestion enzymes (glycoside hydrolases) (Denman and McSweeney, 2015) . A recent global effort on profiling the rumen microbiome using more than 700 samples revealed a core, diet-driven rumen microbiome in ruminant species (Henderson et al., 2015) . Our lab has been focusing on the study of the association between the rumen microbiome and beef cattle feed efficiency using omics-based approaches. These studies revealed that efficient animals (low residual feed intake) harbor different rumen bacterial and methanogen populations compared with that of inefficient animals (high residual feed intake) (Zhou et al., 2009; Hernandez-Sanabria et al., 2010) . Such differences have been reported in other beef populations, such as heifers in Ireland (Carberry et al., 2012) and steers in United States (Myer et al., 2015) . These global associations suggest that microbial markers for the variation in cattle feed efficiency can be identified through in-depth omics analyses of the rumen microbiome. However, efforts in understanding the function of the rumen microbiome in efficient cattle are still in progress. These studies may provide a better understanding of and applications for improving feed efficiency through manipulation of the rumen microbiome. Knowledge on the metabolic capacity of the rumen microbiota to degrade plant cell walls using metagenomics will aid in developing sustainable feeding strategies for ruminants that utilize available feed ingredients effectively and efficiently. Sustainable ruminant production is essential in the future (Eisler et al., 2014) , as it needs to cater to the increasing demand for high quality proteins (meat and milk) against a background of limited resources. Plant cell wall digestion capacity of rumen microbiota can be diet driven (Brulc et al., 2009 ). Hence, metagenome-based studies may provide fundamental understanding of metabolic capacity of rumen microbiota. Moreover, metatranscriptomic approaches can be used to explore the activity/expression of identified fiber-degrading genes and how they change with the diet. The better understanding of the metabolic capacity of rumen microbiota can subsequently be used to design feed rations and supplements that maximize rumen fermentation via manipulating microbial degradation. Unlike human studies, most of these studies are limited by the number of animals and their statistical power; thus, they may not allow linking the microbiome to host phenotype. Besides, these studies are also limited to one geographic location or one management practice, which has an impact on dietary components and available nutrients for microbial degradation. Therefore, it is important to use omics approaches with larger populations representing various management practices and geographic locations to understand the applicability of the findings universally.
Understanding Microbial Colonization in Ruminants Using Omics
Manipulation of diets using direct-fed microbials, prebiotics, or probiotics has long being tested to improve rumen microbial fermentation. However, it is known that the adult rumen microbiome is resistant to subtle dietary changes (high inertia and resilience) and that the changes in microbiome composition can be transitory (only during the period of supplementation) (Weimer, 2015) , suggesting that manipulations of microbiota can be challenging once they are established. In contrast, the microbiota of neonates (human, mouse, calves, and piglets) are more responsive to external pressures, such as the use of antibiotics, dietary changes, and early exposure to mother/dam (Mulder et al., 2011; Arrieta et al., 2015; Malmuthuge et al., 2015a) . The compositional changes in the gut microbiota that are caused by these external factors during early life, therefore, have a long-term impact on host phenotypes (Abecia et al., 2013; Russell et al., 2012) . This implies potential uses of microbial manipulation tools and techniques in neonates that can result in desirable microbial compositions and functions in adult ruminants. Therefore, it is important to understand the gut microbial colonization and the establishment of microbial functions during the early life of calves. Although there are an increasing number of studies that have explored the compositional changes of rumen microbiota during early life, the studies on microbial functionality are very limited (Malmuthuge et al., 2015b) . Li and colleagues (2012) reported the presence of plant polysaccharide-utilizing enzymes even before the introduction of a solid diet, proposing latent fiber digestion capabilities of early rumen microbiota. However, in-depth understanding of the activity of these identified enzymes and their changes with diet and age are required at different omics levels before microbial manipulation tools to improve rumen development and fermentation from early life can be recommended.
Compared with the studies conducted in the rumen microbiome, the lower gastrointestinal tract (small and large intestine) of ruminants has received less attention. There are very few studies that have explored the gut microbial composition, and most of them are based on fecal samples (Malmuthuge et al., 2015b) . These few studies revealed age, diet, and gut region dependent changes in gut bacterial composition (Malmuthuge et al., 2015b) . Oikonomou and colleagues (2013) suggested a link between early fecal microbiota and the host phenotype in dairy calves. From this study, they reported that the higher prevalence of fecal Fecalibacterium prausnitzii during the first week of life was associated with increased body weight gain and decreased diarrhea incidence in calves at the fourth week of life. Hence, calf gut omics can be used to identify different host phenotypes and to predict the host susceptibility to enteric infections as well as growth during early life. Since the use of omics can describe the mechanisms behind such associations that have been identified between the host and its symbiotic microbiota, these techniques may provide potential microbial biomarkers that can be used in animal selection and prediction for healthier and high-production phenotypes. These gut microbiome-based predictions can be used to improve herd health and production via selection of calves with better immune systems and efficient rumen fermentation, respectively.
Future Direction of Studying Host-Microbial Interactions Using Omics
Although metagenomics is capable of exploring the functional abundance (relative abundance of genes presence in a microbiome) of the gut microbiome, this technique does not provide in-depth understanding of the microbial activity (gene expression in live microbes). Therefore, recent studies are using metatranscriptomics (RNA-based) along with metagenomics (DNA-based) to explore the functionality of the active/ alive microbiome and their role in the host physiology. A comparison between the metatrancriptome and the metagenome of individuals, however, revealed that abundance of genes might not necessarily represent their activity/expression (Franzosa et al., 2014) . This study revealed that nearly 22% of gene families identified in the human gut microbiome are over-or under-expressed compared with their gene abundance observed via metagenomics. For example, ribosomal protein coding genes and oxaloacetate production-related genes were under-represented while stress response and peptidoglycan biosynthesis-related genes were overrepresented in metagenomic profiles compared with metatranscriptomic profiles. However, more than half of the microbial functionality (58% of gene families) was similar between these two approaches (Franzosa et al., 2014) . This suggests the importance of DNA-based approaches in understanding the activity in a microbial community. The observed variations in microbial gene expressions compared with their abundances further suggest that the use of broad biochemical pathways to explain the activity of the gut microbiome should be avoided, as a high abundance of some genes in a broad pathway might not necessarily infer activation of that whole pathway. For example, Franzosa and colleagues (2014) suggested that a high expression of genes involved in the second carbon oxidation of citrate cycle along with the oxaloacetate production-related genes (metatranscriptome) represented an increase in anaerobic bacterial metabolism. In contrast, the gene abundance (metagenome) at the level of broad biochemical pathways suggested an increase in the citrate cycle, or aerobic metabolism, which was highly questionable considering obligate anaerobes colonize the gut (Franzosa et al., 2014) . Thus, the use of metagenomics and metatranscriptomics together may provide in-depth understanding of gut microbiome as well as of the mechanisms behind microbial-composition-driven host phenotypes.
Human and mouse studies have further advanced knowledge by studying the metaproteomics and meta-metabolomics to evaluate the microbial proteins and metabolites in linking gut microbiomes to host phenotypes. Although these studies are still at the pilot phase, they have reported differences in microbial metabolites and proteins between diseased and healthy phenotypes (Erickson et al., 2012; Walker et al., 2014) . Moreover, the study of metaproteomics once again suggested that metagenomics could still be used to study the core functionality of the microbiome, but that this may underrepresent the functionality of certain microbiota (Kolmeder et al., 2012) . For example, in one study, the peptides derived from Bifidobacterium, a beneficial bacterium, were abundant in the metaproteome. However, they were less abundant in metagenomic profiles (Kolmeder et al., 2012) . Thus, the comparisons among different omics approaches used to study the gut microbiome suggest that the studying of the gene pool (metagenome) can be a robust tool for linking this microbiome to host phenotypes. Yet, the other tools (metatranscriptomics, metaproteomics) may provide in-depth understanding of identified associations between host and gut microbiota and help in defining the host physiology using the gut microbiome.
Conclusion
Changes in the microbial composition that are associated with metabolic and disease phenotypes of the host can be explained via omics-based studies of the gut microbiome. The use of omics elucidates how the change in microbial functions and activity influences the host physiology and creates various phenotypes in a population. Although omics approaches are widely used in humans to define host phenotypes, its use in ruminant production is still limited. Recent studies are suggesting potential impacts of early gut microbial composition on ruminant health, and growth of preruminants as well as production performances following weaning. Therefore, further use of omics approaches can be used to define the mechanisms behind such associations. This understanding can be used to identify microbial biomarkers associated with various phenotypes that can be helpful in selecting more productive and healthier animals from early life onward. Moreover, the gut microbiota associated with improved health and production can be used as feed supplements to manipulate the gut microbiome during early life to obtain a desirable and healthy rumen/gut microbiome in adult ruminants. This may play an important role in maintaining sustainable ruminant production in future.
